Skip Navigation

Health and Science

Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly

CNBC Investing Club

Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly

Kevin StankiewiczFri, Dec 1st 2023

Pfizer to pull twice-daily weight loss pill due to tolerability issues

Pfizer to pull twice-daily weight loss pill due to tolerability issues

Annika Kim ConstantinoFri, Dec 1st 2023

Novo Nordisk sues two pharmacies over tainted Wegovy, Ozempic knockoffs

Novo Nordisk sues two pharmacies over tainted Wegovy, Ozempic knockoffs

Annika Kim ConstantinoThu, Nov 30th 2023

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen

Annika Kim ConstantinoThu, Nov 30th 2023

Cramer blasts prospect of Humana-Cigna deal: Regulators would never approve it

CNBC Investing Club

Cramer blasts prospect of Humana-Cigna deal: Regulators would never approve it

Kevin StankiewiczThu, Nov 30th 2023

Nashville's startup scene booms as health-tech founders flock to Music City

Cities of Success

Nashville's startup scene booms as health-tech founders flock to Music City

Thu, Nov 30th 2023

U.S. Covid vaccine rates are slumping — and it will be a challenge to boost them

Health and Science

U.S. Covid vaccine rates are slumping — and it will be a challenge to boost them

Thu, Nov 30th 2023

Health and Science

Cigna, Humana shares fall after report health-care giants are in talks to merge

Wed, Nov 29th 2023

CNBC Pro

Citi is so bullish on this biotech stock it gives it 800% potential upside

Thu, Nov 30th 2023

Morning Meeting

CNBC Investing Club

Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted

Mon, Nov 27th 2023

Trending Now